GREGORY SWART: Open Payments
NPI 1255352183 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 64 payments from 14 companies in 2025. Trend: 2023 $2,021 · 2024 $305 · 2025 $1,241
Food & beverage: $1,241
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $264 |
| AstraZeneca Pharmaceuticals LP | 10 | $262 |
| ABBVIE INC. | 11 | $218 |
| Novo Nordisk Inc | 8 | $136 |
| Exact Sciences Corporation | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Inspire Medical Systems, Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
Products named: UBRELVY, NURTEC ODT, ELIQUIS, FARXIGA, Kerendia, QULIPTA, Ozempic, Wegovy.
Industry payments across WA — which companies pay providers there.
